CF
CNA Financial Portfolio holdings
AUM
$195M
1-Year Return
20.43%
This Quarter Return
+6.9%
1 Year Return
+20.43%
3 Year Return
+79.36%
5 Year Return
+144.91%
10 Year Return
+226.32%
AUM
$353M
AUM Growth
+$27.6M
(+8.5%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
214
New
16
Increased
71
Reduced
52
Closed
19
Top Buys
| 1 |
GRSV
Gores Holdings V, Inc.
GRSV
|
$11.1M |
| 2 |
General Motors
GM
|
$5.92M |
| 3 |
CoStar Group
CSGP
|
$4.14M |
| 4 |
Enterprise Products Partners
EPD
|
$2.41M |
| 5 |
DNB
Dun & Bradstreet
DNB
|
$2.14M |
Top Sells
| 1 |
Visa
V
|
$5.29M |
| 2 |
Cisco
CSCO
|
$4.14M |
| 3 |
AdaptHealth
AHCO
|
$3.68M |
| 4 |
CME Group
CME
|
$1.81M |
| 5 |
CVS Health
CVS
|
$1.67M |
Sector Composition
| 1 | Technology | 23.29% |
| 2 | Healthcare | 18.9% |
| 3 | Financials | 14.11% |
| 4 | Industrials | 11.16% |
| 5 | Consumer Discretionary | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAR
151
DELISTED
Eargo, Inc. Common Stock
EAR
| $581K | 0.16% |
728
| – | – |
|
152
Treace Medical Concepts
TMCI
$453M
| $578K | 0.16% |
+18,504
| New | +$578K |
|
153
Vir Biotechnology
VIR
$732M
| $565K | 0.16% |
11,942
+1,070
| +10% | +$50.6K |
|
154
Holley
HLLY
$469M
| $561K | 0.16% |
56,092
+33,367
| +147% | +$334K |
|
155
Liberty Broadband Class C
LBRDK
$8.61B
| $559K | 0.16% |
3,217
| – | – |
|
156
Insmed
INSM
$30.7B
| $551K | 0.16% |
19,344
+1,350
| +8% | +$38.5K |
|
157
Array Technologies
ARRY
$1.37B
| $546K | 0.15% |
35,022
-1,110
| -3% | -$17.3K |
|
158
National Vision
EYE
$1.86B
| $545K | 0.15% |
+10,650
| New | +$545K |
|
|
RVNC
159
DELISTED
Revance Therapeutics, Inc.
RVNC
| $507K | 0.14% |
17,100
-2,700
| -14% | -$80.1K |
|
160
ACV Auctions
ACVA
$2.03B
| $505K | 0.14% |
+19,687
| New | +$505K |
|
|
FSR
161
DELISTED
Fisker Inc.
FSR
| $493K | 0.14% |
25,580
+8,130
| +47% | +$157K |
|
162
Chefs' Warehouse
CHEF
$2.61B
| $493K | 0.14% |
+15,480
| New | +$493K |
|
163
Janus International
JBI
$1.44B
| $492K | 0.14% |
+34,836
| New | +$492K |
|
164
Recursion Pharmaceuticals
RXRX
$2.01B
| $490K | 0.14% |
+13,432
| New | +$490K |
|
165
First Advantage
FA
$2.79B
| $488K | 0.14% |
+24,500
| New | +$488K |
|
166
Zentalis Pharmaceuticals
ZNTL
$126M
| $482K | 0.14% |
9,066
-2,380
| -21% | -$127K |
|
|
ALLK
167
DELISTED
Allakos
ALLK
| $464K | 0.13% |
5,440
+350
| +7% | +$29.9K |
|
168
Madison Square Garden
MSGS
$4.71B
| $454K | 0.13% |
2,631
| – | – |
|
169
SelectQuote
SLQT
$358M
| $454K | 0.13% |
23,560
-11,692
| -33% | -$225K |
|
170
Allogene Therapeutics
ALLO
$255M
| $450K | 0.13% |
17,271
+2,295
| +15% | +$59.8K |
|
171
Y-mAbs Therapeutics
YMAB
$390M
| $449K | 0.13% |
13,290
+910
| +7% | +$30.7K |
|
172
Legend Biotech
LEGN
$6.66B
| $438K | 0.12% |
10,665
-1,867
| -15% | -$76.7K |
|
173
Relay Therapeutics
RLAY
$710M
| $436K | 0.12% |
11,909
+1,060
| +10% | +$38.8K |
|
|
ALTR
174
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $435K | 0.12% |
6,311
| – | – |
|
175
Instil Bio
TIL
$213M
| $422K | 0.12% |
1,092
+161
| +17% | +$62.2K |
|